Zenodo
What is the evidence regarding the effects of GLP-1 receptor agonists on depression?
By Tripdatabase.
Abstract
GLP-1 receptor agonists may offer modest antidepressant effects, particularly in patients with Type 2 diabetes, though evidence is inconsistent and more direct research is needed.
Keywords
- Diabetes Treatment and Management
- GLP-1 receptor agonists
- depression
- antidepressant effects
- type 2 diabetes
- evidence synthesis
- Open access
Source
Published in Zenodo (CERN European Organization for Nuclear Research). The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
At a glance
- Journal
- Zenodo